NCT01805232

Intravenous Artesunate and Malaria

Intravenous Artesunate Versus Quinine in Severe Malaria at Kassla, Sudan

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: University of Khartoum · Academic / Other
• Sex: All
• Age: 1 Year – 80 Years
• Healthy volunteers: Not accepted

Summary

Intravenous artesunate is egual to quinine in the treatment of severe malaria

Detailed description

Intravenous artesunate is egual to quinine in the treatment of severe malaria in the form of fever clearance time and parasite clearance time

Conditions

• Malaria

Interventions

Type	Name	Description
DRUG	artesunate	intravenous artesunate 80 mg/kg initially then after 8 hours then daily
DRUG	Quinine	quinine infusion 80 mg/kg every 8 hours till the patient can take orally

Timeline

• Start date: 2013-03-01
• Primary completion: 2013-05-01
• Completion: 2013-07-01
• First posted: 2013-03-06
• Last updated: 2013-03-06

Locations

1 site across 1 country: Sudan